Despite this, most studies are limited to the role of IGFBP5 in cancer, including breast cancer (Dittmer, 2022), colorectal cancer (Deng et al., 2022), and ovarian cancer (Fan et al., 2024). This evidence concerns the gene IGFBP5 and breast carcinoma.